{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:30:39Z","timestamp":1786494639945,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.farma.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:15:01Z","timestamp":1786493701000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes"],"prefix":"10.1016","author":[{"given":"Inmaculada","family":"Romero-Zayas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"de Arcocha-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Pe\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mart\u00ednez Montalb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Plancha Mansanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio de Jes\u00fas","family":"Fern\u00e1ndez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"P\u00e9rez Iruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.farma.2026.07.006_bb0005","first-page":"1014","article-title":"Indium-111-labeled autologous leukocytes in man","volume":"18","author":"Thakur","year":"1977","journal-title":"J Nucl Med"},{"issue":"8513","key":"10.1016\/j.farma.2026.07.006_bb0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(86)90601-X","article-title":"Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation","volume":"2","author":"Peters","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.farma.2026.07.006_bb0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00259-010-1394-4","article-title":"Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation\/Infection Taskgroup of the European Association of Nuclear Medicine [published correction appears in Eur J Nucl Med Mol Imaging 2010 Jun;37(6):1235]","volume":"37","author":"de Vries","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.farma.2026.07.006_bb0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00259-010-1393-5","article-title":"Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation\/infection taskgroup of the European Association of Nuclear Medicine [published correction appears in Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1234]","volume":"37","author":"Roca","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.farma.2026.07.006_bb0025","series-title":"IAEA human health series no. 5","article-title":"Radiolabelled autologous cells: methods and standardization for clinical use","author":"International Atomic Energy Agency","year":"2015"},{"key":"10.1016\/j.farma.2026.07.006_bb0030","first-page":"135925","article-title":"Orden SND\/939\/2022, de 29 de septiembre, por la que se aprueban las normas de correcta preparaci\u00f3n extempor\u00e1nea de radiof\u00e1rmacos","year":"2022","journal-title":"Bolet\u00edn Oficial del Estado, n\u00fam. 238"},{"issue":"10","key":"10.1016\/j.farma.2026.07.006_bb0035","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00259-018-4052-x","article-title":"Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline","volume":"45","author":"Signore","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"12","key":"10.1016\/j.farma.2026.07.006_bb0040","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/gut.32.12.1502","article-title":"Value of positive technetium-99\u202fm leucocyte scans in predicting intestinal inflammation","volume":"32","author":"Gibson","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.farma.2026.07.006_bb0045","first-page":"62977","volume":"n\u00fam. 177","author":"Real Decreto Legislativo 1\/2015, de 24 de julio, por el que se aprueba el texto refundido de la Ley de garant\u00edas y uso racional de los medicamentos y productos sanitarios. Bolet\u00edn Oficial del Estado","year":"2015"},{"key":"10.1016\/j.farma.2026.07.006_bb0050","first-page":"45652","volume":"n\u00fam. 267","author":"Real Decreto 1345\/2007, de 11 de octubre, por el que se regula el procedimiento de autorizaci\u00f3n, registro y condiciones de dispensaci\u00f3n de los medicamentos de uso humano fabricados industrialmente. Bolet\u00edn Oficial del Estado","year":"2007"},{"key":"10.1016\/j.farma.2026.07.006_bb0055","unstructured":"Roca Engronyat M, Mart\u00edn-Com\u00edn J, Ricart Brulles Y, Mora Salvad\u00f3 J, Baj\u00e9n L\u00e1zaro MT, Puchal A\u00f1\u00e9 R. M\u00e9todos de marcaje de leucocitos. En: Mart\u00edn-Com\u00edn J, Ab\u00f3s Olivares MD, eds. Diagn\u00f3stico de la inflamaci\u00f3n y de la infecci\u00f3n en medicina nuclear. Simed Software; 2005:77\u201392."},{"issue":"3","key":"10.1016\/j.farma.2026.07.006_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00006231-199603000-00012","article-title":"Gallbladder visualization in 99mTc-HMPAO autologous white cell scintigraphy","volume":"17","author":"Neilly","year":"1996","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.farma.2026.07.006_bb0065","series-title":"Research Ethics Board. Pediatric Blood Volume Draw Guidance Document. Version 3.2","year":"2013"},{"issue":"6","key":"10.1016\/j.farma.2026.07.006_bb0070","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/RLU.0b013e3182173954","article-title":"Tc-99m exametazime (HMPAO)-labeled leukocyte scintigraphy in premature infants: detection and localization of necrotic enterocolitis and osteomyelitis","volume":"36","author":"Koranda","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.farma.2026.07.006_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.mnm.0000172741.36488.f7","article-title":"Succinylated gelatine: an alternative to hydroxyethyl starch for labelling leukocytes with 99mTc-HMPAO","volume":"26","author":"Roca","year":"2005","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.farma.2026.07.006_bb0080","author":"Bot PLUS Web"},{"key":"10.1016\/j.farma.2026.07.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4368342","article-title":"Labelling and clinical performance of human leukocytes labeled with 99mTc-HMPAO using Leukokit\u00ae with Gelofusine versus Leukokit\u00ae with HES as sedimentation agent","volume":"2019","author":"Auletta","year":"2019","journal-title":"Contrast Media Mol Imag"},{"key":"10.1016\/j.farma.2026.07.006_bb0090","author":"CIMA: Centro de Informaci\u00f3n de Medicamentos de la AEMPS"},{"issue":"5","key":"10.1016\/j.farma.2026.07.006_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0212-6982(02)72105-8","article-title":"M\u00e9todo r\u00e1pido de marcaje de leucocitos con 99mTc HM-PAO [Fast method of labelling leukocytes with 99mTc HM PAO]","volume":"21","author":"Piera","year":"2002","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.farma.2026.07.006_bb0100","unstructured":"Ellis B. Radiolabelling of blood cells: theory and practice. En: Theobald T, ed. Sampson's textbook of radiopharmacy. 4th ed. London: Pharmaceutical Press; 2010. p. 421\u2013443."},{"key":"10.1016\/j.farma.2026.07.006_bb0105","author":"CIMA: Centro de Informaci\u00f3n de Medicamentos de la AEMPS"},{"key":"10.1016\/j.farma.2026.07.006_bb0110","author":"CIMA: Centro de Informaci\u00f3n de Medicamentos de la AEMPS"},{"issue":"8","key":"10.1016\/j.farma.2026.07.006_bb0115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00006231-199108000-00007","article-title":"99Tcm-exametazime-labeled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling","volume":"12","author":"Sampson","year":"1991","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.farma.2026.07.006_bb0120","author":"CIMA: Centro de Informaci\u00f3n de Medicamentos de la AEMPS"},{"issue":"5","key":"10.1016\/j.farma.2026.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00259-014-2731-9","article-title":"Pediatric radiopharmaceutical administration: harmonization of the 2007 EANM pediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines","volume":"41","author":"Lassmann","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"10.1016\/j.farma.2026.07.006_bb0130","first-page":"689","article-title":"Indium-111\u2013labeled white blood cells: dosimetry in children","volume":"29","author":"Gainey","year":"1988","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.farma.2026.07.006_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41181-020-00117-6","article-title":"Implementation and validation of an in-house combined fluorescein\/media-fill test to qualify radiopharmacy operators","volume":"6","author":"Fersing","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.farma.2026.07.006_bb0140","article-title":"Alteraciones en la biodistribuci\u00f3n de los radiof\u00e1rmacos causadas por interacciones medicamentosas","author":"Mart\u00ednez","year":"2016","journal-title":"Alasbimn J"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:15:07Z","timestamp":1786493707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S1130634326001753"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.07.006","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}